Valuation: Hologic, Inc.

Market Cap 16.97B 14.71B 13.79B 12.57B 23.66B 1,619B 24.03B 162B 63.38B 811B 63.71B 62.33B 2,704B P/E 2024
24.3x
P/E 2025 27x
Enterprise Value 17.39B 15.07B 14.13B 12.88B 24.24B 1,660B 24.63B 166B 64.95B 831B 65.29B 63.87B 2,771B EV / Sales 2024
4.74x
EV / Sales 2025 3.75x
Free-Float
73.08%
Yield 2024 *
-
Yield 2025 -
1 day+0.48%
6 months+1.29%
Current year+2.04%
Current year 74.49
Extreme 74.49
76.07
1 year 63.19
Extreme 63.1923
76.07
3 years 51.9
Extreme 51.9
84.67
5 years 51.9
Extreme 51.9
87.88
10 years 26.49
Extreme 26.49
87.88
Manager TitleAgeSince
Chief Executive Officer 63 07/04/2026
Director of Finance/CFO - 16/04/2026
Chief Operating Officer 46 01/01/2024
Director TitleAgeSince
Director/Board Member 63 07/04/2026
Date Insider Type Main position Quantity % Market Cap.
7/4/26 Issuer sale

Director

23,407 0.0105%
27/2/26 Tax

General Counsel

185 0.0001%
26/2/26 Free

Director

3,190 0.0014%
Change 5-day change 1-year change 3-year change Capi.($)
+0.48%-.--%+10.19%+0.96% 16.97B
-1.18%+2.74%+22.92%+9.58% 220B
-0.92%+1.96%-2.51%-20.17% 143B
0.00%+7.37%-16.81%+31.78% 142B
+0.53%+4.85%-49.57%+1.29% 74.91B
-0.53%+3.63%+19.16%+16.56% 53.35B
+0.68%-0.48%-15.95%-16.54% 50.13B
+0.71%+5.62%+24.11%+17.68% 42.16B
-0.63%+3.46%+39.31%+41.78% 40.63B
+2.09%+4.95%-2.04%+3.07% 33.33B
Average +0.32%+3.60%+2.88%+8.60% 81.69B
Weighted average by Cap. -0.14%+3.77%+1.88%+7.88%

Financials

2024 2025
Net sales 4.03B 3.49B 3.27B 2.99B 5.62B 385B 5.71B 38.56B 15.05B 193B 15.13B 14.8B 642B 4.1B 3.55B 3.33B 3.04B 5.72B 391B 5.81B 39.23B 15.32B 196B 15.39B 15.06B 654B
Net income 790M 684M 642M 585M 1.1B 75.35B 1.12B 7.55B 2.95B 37.72B 2.96B 2.9B 126B 566M 490M 460M 419M 789M 53.99B 801M 5.41B 2.11B 27.03B 2.12B 2.08B 90.16B
Net Debt 321M 279M 261M 238M 448M 30.66B 455M 3.07B 1.2B 15.35B 1.21B 1.18B 51.21B 421M 365M 342M 312M 587M 40.17B 596M 4.03B 1.57B 20.11B 1.58B 1.55B 67.08B
Logo Hologic, Inc.
Hologic, Inc. is a medical technology company primarily focused on improving women's health and well-being through early detection and treatment. The Company is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment offers a range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast imaging, biopsy, breast surgery and pathology. The GYN Surgical segment's products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Acessa ProVu laparoscopic radiofrequency ablation system, as well as CoolSeal vessel sealing portfolio and JustRight surgical stapler. The Skeletal Health segment's products include the Horizon DXA and the Fluoroscan Insight FD mini C-arm.
Employees
7,070
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
AA
  1. Stock Market
  2. Stocks
  3. HOLX Stock